MENTER, A. M.; DRAELOS, Z.; HEIM, J.; GOGINENI, R.; GRIFFITHS, C. E. Efficacy and safety by body weight decile in patients treated with tildrakizumab 100 mg for 28 weeks: Pooled data analysis of reSURFACE 1 and reSURFACE 2. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. s136, 2023. DOI: 10.25251/skin.7.supp.136. Disponível em: https://jofskin.org/index.php/skin/article/view/2007. Acesso em: 3 jul. 2024.